S 545 · 119th CongressIn Committeecongress.gov ↗

Combating Illicit Xylazine Act

Road to The Floor

How it works

Introduced

In Committee

On The Floor

Passed a Chamber

Passed Congress

To President

Became Law

What this bill does

AI plain-language summary

This bill makes xylazine, a sedative used in animals that is sometimes called "tranq," a controlled substance under federal drug law. It places xylazine in the same category as drugs like ketamine, meaning it would be illegal to make, sell, or hand out xylazine for illegal purposes, and people who do so could face criminal penalties. The bill makes exceptions so that veterinarians, pharmacies, and animal-control programs can still legally use xylazine for animals. It also requires the DEA to track xylazine transactions and to send Congress a report explaining how it previously decided whether xylazine should be a controlled substance.

Introduced

February 12, 2025

Policy Area

Crime and Law Enforcement

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.